|
BigTrunk Communications has been awarded the digital marketing mandate for Soframycin, one of India’s trusted antiseptic cream brands from the Encube Ethicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of Encube Ethicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s efforts in topical formulations adds deep credibility to Soframycin’s legacy.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Ajay Rawal, vice president – marketing, Soframycin.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science. We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new,” stated Bharat Subramaniam, founder & managing director of BigTrunk Communications.”
|